Pre-eclampsia

@article{Steegers2010Preeclampsia,
  title={Pre-eclampsia},
  author={Eric A. P. Steegers and Peter von Dadelszen and Johannes J Duvekot and Robert Pijnenborg},
  journal={The Lancet},
  year={2010},
  volume={376},
  pages={631-644}
}
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster of varying clinical features. Poor early placentation is especially associated with early onset disease. Predisposing cardiovascular or metabolic risks for endothelial dysfunction, as part of an exaggerated systemic inflammatory response, might… Expand

Paper Mentions

Observational Clinical Trial
An increasing number of scientific publications show that high blood pressure is being described in younger and younger children of African ancestry. It therefore makes sense to… Expand
ConditionsOffspring of Pre-eclamptic Mothers
Interventional Clinical Trial
This implementation study aims to evaluate the efficacy, acceptability, and safety of first-trimester screening and prevention for preterm-preeclampsia. It is a multicenter… Expand
ConditionsPre-Eclampsia
InterventionOther
Interventional Clinical Trial
In 2017, the American College of Cardiology and the American Heart Association changed the diagnostic criteria for hypertension in non-pregnant adults. The parameters for the diagnosis… Expand
ConditionsPre-Eclampsia
InterventionDrug
Interventional Clinical Trial
Background: 1. Burden: Hypertensive disorders of pregnancy, including preeclampsia, complicate up to 10% of pregnancies worldwide, constituting one of the greatest… Expand
ConditionsHypertension, Essential Hypertension, Hypertension in Pregnancy, Hypertension; Pre-Eclampsia, (+1 more)
InterventionDevice
DIFFERENTIATED APPROACH TO RISK ASSESSMENT OF DEVELOPING PLACENTA-ASSOCIATED COMPLICATIONS IN PREGNANT WOMAN WITH PREECLAMPSIA
TLDR
It has been shown that the markers of the propensity to develop obstetric and perinatal complications in pregnant women with preeclampsia are the following gene polymorphisms: 1691 GA in gene factor V Leiden and 20210 AA in prothrombin gene, which are associated with severe pre-eClampsia, early onset and development of life-threatening maternal and fetal complications. Expand
Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial)
TLDR
The PHOENIX trial aims to address the uncertainty for women where the balance of benefits and risks of delivery compared to expectant management are uncertain and to influence clinical practice internationally, through direct adoption and by incorporation into guidelines in countries with similar settings. Expand
Placental morphology and the prediction of underlying cardiovascular risk factors.
TLDR
The findings of the current study identify clinical measurements that can be collected at the time of delivery which may help identify specific women who may benefit most from postpartum cardiovascular risk screening and intervention. Expand
Increased proteinuria and uric acid levels are associated with eclamptic crisis.
TLDR
The data suggest that the combination of high levels of maternal serum uric acid and proteinuria are strongly associated with the development of eclamptic crises. Expand
Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
TLDR
Earlier initiation of eculizumab treatment may potentially shorten and mitigate the disease and hypothetically decrease future health risks of preeclamptic women. Expand
Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial)
TLDR
The CRADLE-4 Trial is the first trial evaluating the optimal timing of delivery in pre-eclampsia in LMIC, where resources and disease burden are considerably different and the balance of risks and benefits needs to be carefully assessed. Expand
Acute Cardiac Effects of Severe Pre-Eclampsia.
TLDR
Women with PEC have higher RVSP, higher rates of abnormal diastolic function, decreased global RVLSS, increased left-sided chamber remodeling, andHigher rates of peripartum pulmonary edema, when compared with healthy pregnant women. Expand
Renal complications during pregnancy: In the hypertension spectrum.
TLDR
The hemodynamic and vascular changes, anatomical and physiologic renal adaptations occurring during normal pregnancy and the complications which arise in the setting of hypertensive diseases are discussed. Expand
Epidemiology and maternal prognosis of hypertension disorders of pregnancy in French Guiana.
TLDR
The study shows a high prevalence of PE in patients with HDP, and hospitalization and repeated clinical evaluation are needed to screen for women exposed to develop PE or severe PE. Expand
Human Placental Vascular Reactivity in Health and Disease: Implications for the Treatment of Pre-eclampsia.
TLDR
This approach highlights the different pathways that are involved in the vascular regulation of the human placenta, changes that occur during PE and the importance of focusing on restoring these dysfunctional systems when studying treatment strategies for PE. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 155 REFERENCES
Management of pre-eclampsia
TLDR
Current evidence on management of pre-eclampsia is summarized, which includes identification and referral of women at high risk, prompt diagnosis with prevention and treatment of complications, and timely delivery (the only definitive cure). Expand
Neurologic complications of pre-eclampsia.
  • G. Zeeman
  • Medicine
  • Seminars in perinatology
  • 2009
TLDR
It may be the acuity of the blood pressure rise in the setting of endothelial dysfunction that interrupts the delicate balance between capillary and cellular perfusion pressures that leads to the neurological complications of pre-eclampsia. Expand
The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community
TLDR
The pre-eclampsia community guideline provides an evidence based risk assessment, with criteria for early referral for specialist input, a two tiered schedule for monitoring women in the community after pregnancy, and no uniformity in referral thresholds and assessment procedures. Expand
Imitators of severe pre-eclampsia.
  • B. Sibai
  • Medicine
  • Seminars in perinatology
  • 2009
TLDR
This review focuses on diagnosis, management, and counseling of women who develop these syndromes based on results of recent studies and my own clinical experience. Expand
Interventionist versus expectant care for severe pre-eclampsia before term.
TLDR
There is insufficient data for any reliable recommendation about which policy of care should be used for women with severe early onset pre-eclampsia, and further large trials are needed. Expand
Diagnosis and management of atypical preeclampsia-eclampsia.
TLDR
The purpose of this review was to increase awareness of the nonclassic and atypical features of preeclampsia-eClampsia and a stepwise approach toward diagnosis and treatment of patients with these atypICAL features is described. Expand
The global impact of pre-eclampsia and eclampsia.
  • L. Duley
  • Medicine
  • Seminars in perinatology
  • 2009
TLDR
Although it is a low cost effective treatment, magnesium sulfate is not available in all low and middle income countries; scaling up its use for eClampsia and severe preeclampsia will contribute to achieving the Millennium Development Goals. Expand
Psychological treatment of women with psychological complaints after pre-eclampsia
TLDR
Psychological treatment in cases of psychological complaints increases coping possibilities in women after exposure to PE and timely recognition reduces the treatment duration. Expand
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
TLDR
Antiplatelet agents during pregnancy are associated with moderate but consistent reductions in the relative risk of pre-eclampsia, of birth before 34 weeks' gestation, and of having a pregnancy with a serious adverse outcome. Expand
Corticosteroids for HELLP syndrome in pregnancy.
TLDR
There is insufficient evidence to determine whether adjunctive steroid use in HELLP syndrome decreases maternal and perinatal mortality, major maternal andperinatal morbidity. Expand
...
1
2
3
4
5
...